These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 8795646

  • 1. Chronic viral hepatitis and use of interferon. Whom are we treating?
    Koretz RL.
    Postgrad Med; 1996 Sep; 100(3):55-7, 61-2, 68. PubMed ID: 8795646
    [Abstract] [Full Text] [Related]

  • 2. Why we should treat chronic viral hepatitis.
    King PD.
    Postgrad Med; 1996 Sep; 100(3):68-70, 73; discussion 73, 78. PubMed ID: 8795647
    [No Abstract] [Full Text] [Related]

  • 3. [Treatment of chronic viral hepatitis].
    Marcellin P, Metreau JM, Pol S, Zoulim F.
    Ann Gastroenterol Hepatol (Paris); 1996 Sep; 32(2):85-7. PubMed ID: 8737503
    [No Abstract] [Full Text] [Related]

  • 4. The treatment of chronic viral hepatitis.
    Hoofnagle JH, di Bisceglie AM.
    N Engl J Med; 1997 Jan 30; 336(5):347-56. PubMed ID: 9011789
    [No Abstract] [Full Text] [Related]

  • 5. [Pathogenesis and alpha-2 interferon treatment of chronic hepatitis B].
    Pirotte J.
    Rev Med Liege; 1996 Aug 30; 51(8):514-21. PubMed ID: 8927872
    [No Abstract] [Full Text] [Related]

  • 6. Clinical course of inflammatory bowel disease during treatment with interferon for associated chronic active hepatitis.
    Cottone M, Magliocco A, Trallori G, Brignola C, Vandelli C, Ardizzone S, Meucci G, Zannoni F, Di Maio G, Astegiano M.
    Ital J Gastroenterol; 1995 Aug 30; 27(1):3-4. PubMed ID: 7795286
    [Abstract] [Full Text] [Related]

  • 7. Management of chronic hepatitis B and C.
    Dusheiko GM.
    S Afr Med J; 1994 Aug 30; 84(8 Pt 2):563-70. PubMed ID: 7863401
    [No Abstract] [Full Text] [Related]

  • 8. Sustained response to interferon in a patient with common variable immunodeficiency and hepatitis C.
    Castro F, Santaella M, Torres EA, Rodriguez-Medina JR, González-Keelan C.
    Am J Gastroenterol; 1997 Sep 30; 92(9):1557-8. PubMed ID: 9317087
    [Abstract] [Full Text] [Related]

  • 9. Development of granulomatous hepatitis during treatment with interferon-alpha 2b.
    Propst A, Propst T, Dietze O, Kathrein H, Judmeier G, Vogel W.
    Dig Dis Sci; 1995 Oct 30; 40(10):2117-8. PubMed ID: 7587776
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Breakthrough of interferon therapy.
    Scalori A, Ricci A, Bellati G, Colloredo G, Roffi L.
    Am J Gastroenterol; 1996 Oct 30; 91(10):2249-50. PubMed ID: 8855768
    [No Abstract] [Full Text] [Related]

  • 13. Therapy of chronic viral hepatitis.
    Fried MW.
    Med Clin North Am; 1996 Sep 30; 80(5):957-72. PubMed ID: 8804370
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Therapy of chronic hepatitis B, C and D with alpha-interferon].
    Niederau C.
    Fortschr Med; 1993 Feb 28; 111(6):35-7. PubMed ID: 8462911
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.